Pneumonia remains a leading cause of morbidity and mortality among critically ill patients in the ICU. Early detection and appropriate therapeutic interventions are essential to optimize patient outcomes. Employing structured diagnostic criteria—such as those recommended by the CDC for ventilator-associated pneumonia (VAP) and other ICU-related pulmonary infections—helps clinicians differentiate VAP from other respiratory conditions and ensures consistency in clinical assessment and management strategies [1–3] [Ref: Algorithm 85.1].